Cargando…
Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
BACKGROUND: Transparency and reproducibility are expected to be normative practices in clinical trials used for decision-making on marketing authorisations for new medicines. This registered report introduces a cross-sectional study aiming to assess inferential reproducibility for main trials assess...
Autores principales: | Siebert, Maximilian, Gaba, Jeanne, Renault, Alain, Laviolle, Bruno, Locher, Clara, Moher, David, Naudet, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119701/ https://www.ncbi.nlm.nih.gov/pubmed/35590360 http://dx.doi.org/10.1186/s12916-022-02377-2 |
Ejemplares similares
-
Funders’ data-sharing policies in therapeutic research: A survey of commercial and non-commercial funders
por: Gaba, Jeanne Fabiola, et al.
Publicado: (2020) -
The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports
por: Erhel, Florian, et al.
Publicado: (2020) -
Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations
por: Siebert, Maximilian, et al.
Publicado: (2020) -
Medical journal requirements for clinical trial data sharing: Ripe for improvement
por: Naudet, Florian, et al.
Publicado: (2021) -
Status, use and impact of sharing individual participant data from clinical trials: a scoping review
por: Ohmann, Christian, et al.
Publicado: (2021)